Rapid declines in total lymphocyte count and hemoglobin in HIV infection begin at CD4 lymphocyte counts that justify antiretroviral therapy.
Gange
Stephen J
SJ
Department of Epidemiology and Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
Lau
Bryan
B
Phair
John
J
Riddler
Sharon A
SA
Detels
Roger
R
Margolick
Joseph B
JB
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D003906:Developing Countries; D005500:Follow-Up Studies; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D006454:Hemoglobins / Q000032:analysis*; D006801:Humans; D018655:Lymphocyte Count; D008297:Male; D018579:Patient Selection
D019380:Anti-HIV Agents; D006454:Hemoglobins